Brief: Jasper Therapeutics terminates Cantor sales agreement
19/03/2025 20:53
March 19 (Reuters) - Jasper Therapeutics Inc JSPR.O: JASPER THERAPEUTICS INC - ON MAR 14, TERMINATED CANTOR SALES AGREEMENT DATED NOV 10, 2022 Source text: [ID:n0001213900-25-025123] Further company coverage: JSPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jasper Therapeutics
See all newsBrief: Jasper Therapeutics Announces Commencement Of An Offer To Purchase Outstanding Warrants
Jasper Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln
Jasper Therapeutics, Inc. expected to post a loss of 35 cents a share - Earnings Preview
Jasper Therapeutics rises; co announces all-stock merger with Kira Pharma